MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
+47.82%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$477M
AUM Growth
+$477M
(+64%)
Cap. Flow
-$42.5M
Cap. Flow
% of AUM
-8.9%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Exelixis
EXEL
|
$37.3M |
| 2 |
Celldex Therapeutics
CLDX
|
$2.91M |
| 3 |
Alkermes
ALKS
|
$2.22M |
Sector Composition
| 1 | Healthcare | 96.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $305M | 63.94% | 12,841,798 -1,572,075 | -11% | -$37.3M |
|
2
Esperion Therapeutics
ESPR
$448M
| $138M | 28.84% | 2,679,835 | – | – |
|
|
3
Alkermes
ALKS
$4.78B
| $14.6M | 3.05% | 750,000 -114,417 | -13% | -$2.22M |
|
4
iShares MSCI India ETF
INDA
$9.17B
| $9.29M | 1.95% | 320,000 | – | – |
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $8.01M | 1.68% | 400,000 | – | – |
|
|
6
Celldex Therapeutics
CLDX
$1.47B
| $2.56M | 0.54% | 196,846 -224,000 | -53% | -$2.91M |
|